SCHEMBL17870798

SCHEMBL17870798

CC1(NC(=O)Cc2ccccc2[N+](=O)[O-])CCN(C(=O)O)CC1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.52
ALDH1A1 P00352 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RAB9A P51151 5/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
NPC1 O15118 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
CYP2C19 P33261 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
POLB P06746 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17870796 1.00 SIGMAR1 (0.52) SIGMAR1ALDH1A1L3MBTL1RAB9AMEN1
SCHEMBL19873822 0.83 SIGMAR1 (0.49) SIGMAR1ALDH1A1L3MBTL1RAB9AMEN1
SCHEMBL17870736 0.83 ALDH1A1 (0.43) SIGMAR1ALDH1A1L3MBTL1RAB9AMEN1
SCHEMBL17870738 0.83 ALDH1A1 (0.43) SIGMAR1ALDH1A1L3MBTL1RAB9AMEN1
SCHEMBL3958147 0.77 HTT (0.44) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL27644978 0.75 RAB9A (0.44) SIGMAR1ALDH1A1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL23236146 0.74 DPP4 (0.44) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL31381443 0.72 MEN1 (0.67) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL7647604 0.72 MEN1 (0.67) ALDH1A1L3MBTL1RAB9AMEN1KMT2A
SCHEMBL2101463 0.71 ALDH1A1 (0.70) SIGMAR1ALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237403-A1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2017-11-01 EP disclosed
WO-2016102882-A1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-06-30 WO disclosed